Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1989-04-14
1993-04-20
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Lymphokine
424 88, 424 86, 424 858, 530324, 530328, 530329, 530350, 514 13, 514 14, 514 15, 514 17, A61K 3912, A61K 3702
Patent
active
052040968
ABSTRACT:
A hepatitis B vaccine containing a peptide with an amino acid chain of at least six consecutive amino acids within the pre-S gene coded region of the envelope of hepatitis B virus. The vaccine being free of an amino acid sequence corresponding to the naturally occurring envelope proteins of hepatitis B virus and a physiologically acceptable diluent. The peptide being free or linked to a carrier. The carrier being a conventional carrier or a novel carrier including a lipid vesicle stabilized by cross-linking and having covalently bonded active sites on the outer surface thereon. Such novel carrier being useful not only to link the novel peptide containing an amino acid chain with amino acids within the pre-S gene coded region of the surface antigen or hepatitis B virus, but can also be used to bind synthetic peptide analogues of other viral proteins, as well as bacterial, allergen and parasitic proteins of man and animals. The peptides of the invention can be utilized in diagnostics for the detection of antigens and antibodies.
REFERENCES:
patent: 4415491 (1983-11-01), Vyas
patent: 4428941 (1984-01-01), Galibert et al.
patent: 4599230 (1986-06-01), Milich et al.
patent: 4683136 (1987-04-01), Milich et al.
patent: 4816564 (1989-03-01), Ellis et al.
patent: 4935235 (1990-06-01), Rutler et al.
Ono et al. "The complete nucleotide sequence of the cloned hepatitis B virus DNA; subtype adr and adw" Nucleic acids Research, vol. 11, No. 6, pp. 1747-1767, 1983.
Valenzuela et al, "Nucleotide sequence of the gene coding for the major protein of hepatitis B surface antigen" Nature, vol. 280, pp. 815-819, 1979.
Chemical Abstracts, vol. 100, No. 19, May 7, 1984, p. 139, ref. No. 1511965c; Columbus, OH, US & JP-A-58 194 897 (Takeda Chem. Ind. Ltd.) Dec. 11, 1983.
Journal of Virology, vol., 46, No. 2, May 1983, pp. 626-628; Am. Soc. for Microbiology, US W. Stibbe et al.; "Structural relationship between minor and major proteins of Hepatitis B surface antigen."
Gastroenterology, vol. 85, No. 2, 1983, pp. 268-274; Am. Gastroenterological Ass., US A. Machida et al.: "A Hepatitis B surface antigen polypeptide (P31) with the receptor for polymerized human as well as chimpanzee albumins."
Proc. Natl. Acad. Sci. USA, vol. 78, No. 6, Jun. 1981, pp. 3824-3828; US, T. P. Hopp et al.; "Prediction of protein antienic determinants from amino acid sequences".
Experientia, vol. 38, No. 5, May 1982, pp. 629-630; Basel, CH P. K. DAS et al.: "Liposomes as immulogical carriers for the preparation of antimannosyl antibodies." pp. 629, column 1, lines 12-13, column 2, lines 1-2.
Gastroenterology, vol. 86, 1984, pp. 910-918; Am. Gastroenterological Ass., US A. Machida et al.: "A polypeptide contanining 55 amino acid residues coded by the pre-S region of Hepatitis B virus deoxyribonucleic acid bears the receptor for polymerized human as well as chimpanzee albumins."
Science, vol. 224, Apr. 27, 1984, pp. 392-395, A. R. Neurath et al.: "Location and chemical synthesis of a pre-S gene coded immunodominant epitope of Hepatitis B virus".
Immunodominant Epitope of Hepatitis B virus, vol. 101, p. 5405 y, (1984).
Chemical Abstracts; Machida et al. A polypeptide containing 55 amino acid residues coded by the pre-S region of hepatitis B virus deoxyribonucleic acid bears the receptor for polymerized human as well as chimpanzee albumins, vol. 101, p. 34692 w, (1984).
Chemical Abstracts; Neurath et al. Location and chemical synthesis of a pre-S gene coded.
A. R. Mitchell, S. B. H. Kent, M. Engelhard and R. B. Merrifield, J. Org. Chem., 43, 2845-2852, (1978).
S. B. H. Kent, M. Riemen, Marie LeDoux, and R. B. Merrifield, Methods in Protein Sequence Analysis, pp. 205-213, Brookhaven Press, Brookhaven, N.Y.), in press, (1981).
S. B. H. Kent, Biomedical Polymers, eds, E. P. Goldberg and A. Nakajima (Academic Press, New York), 213-242, (1980).
W. Szmuness, Prog. Med. Virol., 24, 40 (1978).
R. P. Beasley, L.-Y. Hwang, C.-C. Ling, C.-S. Chien, Lancet, Nov., 21.
Krugman, Viral Hepatitis: Laboratory and Clinical Science, F. Deinhardt, J. Deinhardt, Eds., Marcel Dekker, Inc., New York-Basel, 1983, pp. 257-263.
B. S. Blumberg, Science, 197, 17, (1977).
P. Tiollais, P. Charnay, G. N. Vyas, Science, 213, 406, (1981).
Williams, Am. J. Med. Sci., 270, 165 (1975).
W. Szumuness, C. E. Stevens, E. J. Harley, E. A. Zang, J. J. Alter, P. E. Taylor, A. DeVera, G. T. S. Chen, A. Kellner, et al., N. Engl. J. Med., 307, 1481; (1982).
J. W.-K. Shih, J. L. Gerin, J. Immunol., 115,634 (1975).
J. W.-K. Shih, P. L. Tan, J. L. Gerin, J. Immunol., 120,520 (1978).
S. Mishiro, M. Imai, K. Takahashi, A. Machida, T. Gotanda, Y. Miyakawa, M. Mayumi, J. Immunol., 124, 1589, (1980).
G. R. Dressman, R. Chairez, M. Suarez, F. B. Hollinger, R. J. Courtney, J. L. Melnick, J. Virol., 16, 508, (1975).
N. Williams, Nature, 306, 427, (1983).
A. Machida, S. Kishimoto, H. Ohnuma, H. Miyamoto, K. Baba, K. Oda, T. Nakamura, Y. Miyakawa, M. Mayumi, Gastroenterology, 85, 268, (1983).
Nima, H. L., Houghten, R. A., Walker, L. E., Reisfeld, R. A., Wilson, I. A., Hogle, J. M. and Lerner, R. A., "Generation of Protein-Reactive Antibodies By Short Peptides Is An Event Of High Frequency: Implications For The Structural Basis Of Immune Recognition", Proceedings of the National Academy of Sciences USA, 80 4949-4953, (1983).
Kennedy, R. C., Dressman, G. R., Sparrow, J. T., Culwell, A. R., Sanchez, Y., Ionescu-Matiu, I., Hollinger, R. B. and Melnick, J. L., "Inhibition Of A Common Human Anti-Hepatitis B. Surface Antigen Idiotype By A Cyclic Synthetic Peptide", Journal of Virology, 46, 653-655, (1983).
Dressman, G. R., Sanchez, Y., Ionescu-Matiu, I., Sparrow, J. T., Six. H. R., Peterson, D. L. Hollinger, F. B. and Melnick, J. L., "Antibody To Hepatitis B. Surface Antigen After A Single Inoculation Of Uncoupled Synthesis HBsAg Peptides", Nature, 295, 158-160, (1982).
G. N. Vyas, K R. Rao, A. B. Ibrahim, Science, 178, 1300, (1972).
G. R. Dressman, F. B. Hollinger, R. M. McCombs, J. L. Melnick, J. Gen. Virol., 19, 129, (1973).
A. R. Neurath, N. Strick, J. Med. Virol., 6, 309, (1980).
A. R. Neurath, S. B. H. Kent, and N. Strick, Proc. Natl. Acad. Sci. USA 79, 7871 (1982).
F. Galibert, T. N. Chen, E. Mandart, J. Virol., 41 51, (1982).
Oku, N. Scheerer, J. F., and MacDonald, R. C., "Preparation of Giant Liposomes", Biochimica et Biophysica Acta, 692, 384-388, (1982).
Dancey, G. F., Yasuda, T. and Kinsky, S. C., "Effect of Liposomal Model Membrane Composition On Immunogenicity", The Journal Of Immunology, 120, 1109-1113, (1978).
Alkan, S. S., Nitecki, D. E. and Goodman, J. W., "Antigen Recognition And The Immune Response: The Capacity of 1-Tryosine-Azobenzenezrsonate To Serve As A Carrier For A Macromolecular Hapten", The Journal of Immunology, 107, 353-358, (1971).
Alkan, S. S., Williams, E. B., Nitecki D. E. and Goodman, J. W., "Antigen Recognition And The Immune Response. Hurmoral And Cellular Immune Responses To Small Mono-- And Bifunctional Antigen Molecules", The Journal Of Experimental Medicine, 135, 1228-1246, (1972).
V. P. Torchilin, V. S. Goldmacher and V. N. Smirnov, "Comparative Studies On Covalent And Noncovalent Immobilization of Protein Molecules On The Surface Of Liposomes", Biochemical And Biophysical Research Communications, vol. 85, No. 3, 1978, pp. 983-990.
V. K. Jansons and P. L. Mallett, "Targeted Liposomes: A Method For Preparation And Analysis, Analytical Biochemistry III, pp. 54-59, 1981.
F. J. Martin and D. Papahadjopoulos, "Irreversible Coupling Of Immonogobulin Fragments To Performed Vesicles", The Journal Of Biological Chemistry, vol. 257, No. 1, Jan. 10, 1982, pp. 286-288.
D. Gerlier, "Liposomes As A Tool To Study The Role Of Membrane Presentation In The Immunogenicity Of MVLV-Related Tumor Antigen", J. Immunol., 131, 485, (1983).
L. D. Leserman, "Targeting To Cells Of Fluorescent Liposomes Covalently Coupled With Monoclonal Antibody Or Protein A", Nature, 288, 602, (1980).
M. Tomasi, "Conjugation Of Specific Antibodies To Sendai Virus Particles" A New Tool For Targeting Of Fusogenic Vesicles", Federation of European Biological Letters, 143, 252, (1982).
P. N. Shek, "Im
Kent Stephen B. H.
Neurath Alexander R.
Brown Johnnie R.
California Institute of Technology
Mohamed Abdel A.
New York Blood Center Inc.
LandOfFree
Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagn does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagn, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagn will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1524621